Effect of Concomitant Conventional Disease-Modifying Antirheumatic Drugs (DMARDs) on the Efficacy and Safety of Ixekizumab in Biologic DMARD-Naive Patients with Active Psoriatic Arthritis

被引：0

作者：

Gottlieb, Alice B. ^{[1
]}

Coates, Laura C. ^{[2
]}

Shuler, Catherine L. ^{[3
]}

Lin, Chen-Yen ^{[3
]}

Moriarty, Susan R. ^{[3
]}

Lee, Chin H. ^{[3
]}

Mease, Philip J. ^{[4
,5
]}

机构：

[1] Tufts Univ, Sch Med, Boston, MA 02111 USA

[2] Univ Leeds, Leeds, W Yorkshire, England

[3] Eli Lilly & Co, Indianapolis, IN 46285 USA

[4] Swedish Med Ctr, Rheumatol Res, Seattle, WA USA

[5] Univ Washington, Seattle, WA 98195 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1687

引用

页数：3